This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Goldfarb Branham Law Firm LLP Pursuing Shareholder Claims Against Prospect Medical Holdings, Inc.

Goldfarb Branham LLP is pursuing shareholder claims against the board of Prospect Medical Holdings (NASDAQ: PZZ) in connection with the proposed buyout. The acquisition will cash out investors for $8.50 per share. If you are a Prospect shareholder, you are encouraged to contact the firm at 877-583-2855 or hlindley@goldfarbbranham.com to learn about your rights.

“Company insiders own nearly 50% of Prospect’s shares and have entered into an agreement to vote all their shares in favor of the transaction and agreed to exchange almost 6.2 million of their shares for equity interests in the acquiring company,” said securities lawyer Hamilton Lindley. “Additionally, because at least one analyst has set a price target of $16.20 per share, this deal could be unfair to shareholders. Our proposed class action lawsuit seeks better value for the company as well as more information about this transaction disclosed to shareholders.”

Goldfarb Branham LLP lawyers have significant experience representing shareholders in unfair buyouts nationwide. The national securities firm provides nimble, creative and effective counsel at all stages of litigation. If you have information or concerns about this transaction, contact attorney Hamilton Lindley at the contact numbers listed below.



Copyright Business Wire 2010

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
AAPL $130.28 0.00%
FB $81.53 0.00%
GOOG $565.06 0.00%
TSLA $218.42 0.00%
YHOO $44.52 0.00%

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs